These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4954025)

  • 1. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. II. A possible mechanism for potentiation of the carcinostatic activity of alkylating agents by ferrous glucuronate.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):385-402. PubMed ID: 4954025
    [No Abstract]   [Full Text] [Related]  

  • 2. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):377-84. PubMed ID: 4954024
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of various carcinostatic agents on acridine orange uptake by Ehrlich ascites carcinoma cells.
    Hano K; Iwata H; Morita S
    Gan; 1966 Feb; 57(1):19-26. PubMed ID: 4959535
    [No Abstract]   [Full Text] [Related]  

  • 4. INFLUENCES OF ANTICANCER AGENTS ON THE METABOLISM OF DELTA-AMINOLEVULINIC ACID IN MORMAL AND TUMOR-BEARING MICE.
    HANO K; AKASHI A
    Gan; 1964 Feb; 55():25-40. PubMed ID: 14133995
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of some drugs on hexosamine synthesis in Ehrlich ascites carcinoma cells and on hyaluronic acid content in the ascitic fluid.
    Hano K; Nishino Y
    Gan; 1965 Aug; 56(4):367-75. PubMed ID: 4954023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV; Eremeeva AA; Tereshin IM
    Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
    [No Abstract]   [Full Text] [Related]  

  • 7. Influences of anticancer agents on the activities of liver catalase, uricase, and xanthine oxidase in normal and tumor-bearing mice.
    HANO K; IWATA H; AKASHI A
    Gan; 1963 Mar; 54():47-58. PubMed ID: 13952572
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some aspects of the action mechanism of antimetabolic agents and alkylating antineoplastic agents on the cellular metabolism].
    Roth J
    Hippokrates; 1969 Sep; 40(17):657-64. PubMed ID: 4900608
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of potentiation of the carcinostatic activity of 8-aza-guanine by 4(or 5)-aminoimidazole-5(or 4)-carboxamide analogs.
    Nishio H; Yamamoto I; Kariya K; Hano K
    Chem Pharm Bull (Tokyo); 1969 Mar; 17(3):539-43. PubMed ID: 5792308
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the pharmacological characterization of a permanent in vitro growing strain of Ehrlich ascites tumor cells].
    Schmid I; Karzel K
    Arzneimittelforschung; 1968 Dec; 18(12):1498-500. PubMed ID: 4976453
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitory effects of the arabinosides of 6-mercaptopurine and cytosine on purine and pyrimidine metabolism.
    Kimball AP; Bowman B; Bush PS; Herriot J; LePage GA
    Cancer Res; 1966 Jul; 26(7):1337-43. PubMed ID: 5911573
    [No Abstract]   [Full Text] [Related]  

  • 12. [Variability of the sensitivity of human lymphocytes to the antiproliferative action of alkylating agents].
    Veremko LN; Telegin LIu; Pevnitskii LA
    Biull Eksp Biol Med; 1983 May; 95(5):73-5. PubMed ID: 6405824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STUDIES ON ANTITUMOR SUBSTANCES. I. ANTITUMOR EFFECT OF QUINONE DERIVATIVES CONTAINING AN ALKYLATING GROUP.
    HAYASHI S; UEKI H; UEKI Y
    Gan; 1963 Dec; 54():381-90. PubMed ID: 14099936
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxicity of antitumor agents in a synchronous mammalian cell system.
    Bhuyan BK; Fraser TJ
    Cancer Chemother Rep; 1974; 58(2):149-55. PubMed ID: 4133836
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver regeneration in the presence of antitumor antibiotics and antimetabolites.
    Gershbein LL; Pedroso AF
    Acta Hepatosplenol; 1968; 15(2):89-97. PubMed ID: 4970236
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticancer activity of alkylating agents derived from various diamines and diols on Ehrlich Ascites carcinoma.
    Skinner WA; Scholler J
    Cancer Chemother Rep; 1967 Aug; 51(4):205-11. PubMed ID: 5623729
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of correlation between the carcinostatic effect and the inhibition of glycolysis caused by tris-(beta-chlorethyl)-amine.
    Svec J; Sauermann G
    Chemotherapy; 1970; 15(1):12-8. PubMed ID: 4245149
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacodynamic effect of alkylating cytostatics].
    Maass H
    Dtsch Med J; 1968 Mar; 19(5):137-41. PubMed ID: 4887779
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of iron absorption.
    Van Campen D
    Fed Proc; 1974 Jan; 33(1):100-5. PubMed ID: 4589419
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of alkylants, antimetabolites and chloroquine on oxydative biotransformation reactions and on the excretion of ascorbic acid in the rat.
    Traeger A; Bauer B; Klinger W; Ankermann H
    Acta Biol Med Ger; 1973; 30(3):423-34. PubMed ID: 4800889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.